BDNF and Alzheimer disease: We have found that AD individuals showed high miR-206-3p levels in the plasma, and reducing miR-206-3p expression through brain injection with antagomir can upregulate the level of brain-derived neurotrophic factor (BDNF), decrease Aβ plaque, and enhance learning and memory abilities in AD mice 31.